[1] Zuo TT, Zheng RS, Zeng HM, et al. Female breast cancer incidence and mortality in China, 2013[J]. Thorac Cancer, 2017, 8(3): 214-218. DOI: 10.111/17597714.
[2] Fan L, StrasserWeippl K, Li JJ, et al. Breast cancer in China[J]. Lancet Oncol, 2014, 15(7): e279-e289. DOI: 10.1016/S14702045(13)705679.
[3] Adams JM, Difazio LT, Rolandelli RH, et al. HIF1: a key mediator in hypoxia[J]. Acta Physiol Hung, 2009, 96(1): 19-28. DOI: 10.1556/APhysiol.96.2009.1.2.
[4] Hynninen P, Parkkila S, Huhtala H, et al. Carbonic anhydrase isozymes Ⅱ, Ⅸ, and Ⅻ in uterine tumors[J]. APMIS, 2012, 120(2): 117-129. DOI: 10.1111/j.16000463.2011.02820.x.
[5] Nielsen TO, Hsu FD, Jensen K, et al. Immunohistochemical and clinical characterization of the basallike subtype of invasive breast carcinoma[J]. Clin Cancer Res, 2004, 10(16): 53675374. DOI: 10.1158/10780432.CCR040220.
[6] Zhong H, De Marzo AM, Laughner E, et al. Overexpression of hypoxiainducible factor 1 alpha in common human cancers and their metastases[J]. Cancer Res, 1999, 59(22): 5830-5835.
[7] Meier V, Guscetti F, Roos M, et al. HypoxiaRelated marker GLUT1, CAIX, proliferative index and microvessel density in canine oral malignant neoplasia[J]. PLoS One, 2016, 11(2): e0149993. DOI: 10.1371/journal.pone.0149993.
[8] Ji RC. Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis[J]. Cancer Lett, 2013, 346(1): 6-16. DOI: 10.1016/j.canlet.2013.12.001.
[9] Hu Y, Liu J, Huang H. Recent agents targeting HIF1α for cancer therapy[J]. J Cell Biochem, 2013, 114(3): 498-509. DOI: 10.1002/jcb.24390.
[10] Rankin EB, Giaccia AJ. The role of hypoxiainducible factors in tumorigenesis[J]. Cell Death Differ, 2008, 15(4): 678-685. DOI: 10.1038/cdd.2008.21.
[11] Kitagawa N, Kondo S, Wakisaka N, et al. Expression of seveninabsentia homologue 1 and hypoxiainducible factor 1 alpha: novel prognostic factors of nasopharyngeal carcinoma[J]. Cancer Lett, 2013, 331(1): 52-57. DOI: 10.1016/j.canlet.2012.12.002.
[12] Pastoreková S, Parkkila S, Parkkila AK, et al. Carbonic anhydrase Ⅸ, MN/CA Ⅸ: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts[J]. Gastroenterology, 1997, 112(2): 398-408.
[13] Yang JS, Lin CW, Chuang CY, et al. Carbonic anhydrase Ⅸ overexpression regulates the migration and progression in oral squamous cell carcinoma[J]. Tumour Biol, 2015, 36(12): 9517-9524. DOI: 10.1007/s1327701536928.
[14] Chen Y, Li X, Wu S, et al. Expression of HIF1α and CAIX in nasopharyngeal carcinoma and their correlation with patients′ prognosis[J]. Med Oncol, 2014, 31(12): 304. DOI: 10.1007/s1203201403041.
[15] Li M, Song J, Pytel P. Expression of HIF1 regulated proteins vascular endothelial growth factor, carbonic anhydrase Ⅸ and hypoxia inducible gene 2 in hemangioblastomas[J]. Folia Neuropathol, 2014, 52(3): 234-242.
[16] 袁媛, 张赟, 高宇哲, 等. HIF1α及EMT在不同分子亚型乳腺浸润性导管癌中的表达及意义[J]. 中国妇幼保健, 2015, 30(29): 5054-5058. DOI: 10.7620/zgfybj.j.issn.10014411.2015.29.49.
[17] Giatromanolaki A, Koukourakis MI, Sivridis E, et al. Expression of hypoxiainducible carbonic anhydrase9 relates to angiogenic pathways and independently to poor outcome in nonsmall cell lung cancer[J]. Cancer Res, 2001, 61(21): 7992-7998.
[18] Bartosová M, Parkkila S, Pohlodek K, et al. Expression of carbonic anhydrase Ⅸ in breast is associated with malignant tissues and is related to overexpression of cerbB2[J]. J Pathol, 2002, 197(3): 314-321.
[19] Sadlecki P, Bodnar M, Grabiec M, et al. The role of hypoxiainducible factor1α, glucose transporter1, (GLUT1) and carbon anhygrase Ⅸ in endometrial cancer patients[J]. Biomed Res Int, 2014, 2014: 616850. DOI: 10.1155/2014/616850.
[20] Eckert AW, Lautner MH, Schütze A, et al. Coexpression of Hif1alpha and CAIX is associated with poor prognosis in oral squamous cell carcinoma patients[J]. J Oral Pathol Med, 2010, 39(4): 313-317. DOI: 10.1111/j.16000714.2009.00829.x.
[21] Lendahl U, Lee KL, Yang H, et al. Generating specificity and diversity in the transcriptional response to hypoxia[J]. Nat Rev Genet, 2009, 10(12): 821-832. DOI: 10.1038/nrg2665.
[22] Vleugel MM, Greijer AE, Shvarts A, et al. Differential prognostic impact of hypoxia induced and diffuse HIF1 alpha expression in invasive breast cancer[J]. J Clin Pathol, 2005, 58(2): 172-177. DOI: 10.1136/jcp.2004.019885.
[23] Chiche J, Rouleau M, Gounon PA, et al. Hypoxic enlarged mitochondria protect cancer cells from apoptotic stimuli[J]. J Cell Physiol, 2010, 222(3): 648-657. DOI: 10.1002/jcp.21984.
[24] Jain RK. Transport of molecules, particles, and cells in solid tumors[J]. Annu Rev Biomed Eng, 1999, 1: 241-263. DOI: 10.1146/annurev.bioeng.1.1.241.
[25] Wang HB, Zhang HJ, Su JM, et al. Epithelialmesenchymal transition (EMT) and its effect on microRNA expression in lung cancer[J]. Zhonghua Zhong Liu Za Zhi, 2011, 33(8): 590-593. |